Benefits in early use of eribulin in metastatic breast cancer: A 7-year UHNM experience

Yoganayagam, N.; Tripathy, A.; Exton, S.; Rawet, T.; Wu, K.S.; Brunt, A.M.; Gahir, D.; Jegannathen, A.

Abstract

Meeting abstract from 11th European Breast Cancer Conference (EBCC), Barcelona, Spain, Mar 21-23, 2018.

Citation

Yoganayagam, N., Tripathy, A., Exton, S., Rawet, T., Wu, K., Brunt, A., Gahir, D., & Jegannathen, A. (2018, March). Benefits in early use of eribulin in metastatic breast cancer: A 7-year UHNM experience. Paper presented at THE 11TH EUROPEAN BREAST CANCER CONFERENCE, Barcelona, Spain

• Presentation Conference Type: Conference Paper (unpublished)
• Conference Name: THE 11TH EUROPEAN BREAST CANCER CONFERENCE
• Start Date: Mar 21, 2018
• End Date: Mar 23, 2018
• Publisher: Elsevier
• DOI: https://doi.org/10.1016/S0959-8049%2818%2930579-3
• Public URL: https://keele-repository.worktribe.com/output/415187
• Publisher URL: https://www.sciencedirect.com/science/article/pii/S0959804918305793
• Related Public URLs: https://www.sciencedirect.com/journal/european-journal-of-cancer/vol/92/suppl/S3